Interestingly, Lonskaya et al. show that nilotinib improves autophagic machinery, leading to Aβ clearance in transgenic amyloid precursor protein (APP) mice, thus suggesting therapeutic benefits for AD [88]. This evidence concerns the gene APP and Alzheimer disease.